MAPT and tauopathy: Several aspects of tau pathology in tauopathy patients have been successfully modelled in transgenic mice overexpressing human tau, including tau-associated processes such as neuroinflammation, synapse loss, neurodegeneration, and cognitive impairment [14,15].